Financial Synergies Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-418
Closed -$26.7K 502
2023
Q2
$26.7K Buy
418
+3
+0.7% +$201 ﹤0.01% 143
2023
Q1
$28.7K Buy
+415
New +$29.3K ﹤0.01% 143

Other funds holding BMY

Financial Synergies Wealth Advisors's BMY Position: Q3 2023 in Review

Financial Synergies Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 418 shares — an estimated $26.7K sold.

Financial Synergies Wealth Advisors first reported a position in BMY in Q1 2023 and held it in 2 quarters. The position peaked at $28.7K in Q1 2023. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Financial Synergies Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Financial Synergies Wealth Advisors sold 418 Bristol-Myers Squibb shares in Q3 2023, an estimated $26.7K.
  • Financial Synergies Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 2 quarters.
  • Financial Synergies Wealth Advisors's Bristol-Myers Squibb position peaked at $28.7K in Q1 2023.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Financial Synergies Wealth Advisors's 13F filing for Q3 2023, filed 4 Apr 2024.